ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0310

Histopathology, Salivary Flow and Ultrasonography of the Parotid Gland: Three Complementary Measurements in Primary Sjögren’s Syndrome

Martha S. van Ginkel1, Esther Mossel2, Erlin A. Haacke2, Suzanne Arends3, Silvia Liefers1, Konstantina Delli1, Jolien F. van Nimwegen4, Alja J. Stel5, Fred Spijkervet1, Arjan Vissink6, Bert van der vegt1, Frans Kroese3 and Hendrika Bootsma3, 1University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 2University of Groningen, University Medical Center Groningen, Groningen, 3University Medical Center Groningen, Groningen, Netherlands, 4Univeristy of Groningen, University Medical Center Groningen, Groningen, Netherlands, 5University of Groningen, University Medical Centre Groningen, Groningen, Netherlands, 6University of Groningen, University Medical Center Groningen, Leek, Netherlands

Meeting: ACR Convergence 2021

Keywords: Sjögren's syndrome, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Sjögren's Syndrome – Basic & Clinical Science Poster (0296–0322)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Primary Sjögren’s syndrome is a systemic autoimmune disease characterized by dryness of the mouth and eyes. The impact of the disease on salivary glands can be assessed in three different ways: by salivary gland histopathology, measuring salivary flow and salivary gland ultrasonography. To understand the relative value of these different approaches for disease evaluation, it is crucial to understand the relationship between them. As we are in the unique position to explore this relationship in the parotid gland, we aimed to assess construct validity between the three different modalities in the same parotid gland.

Methods: Consecutive patients underwent a diagnostic work-up including a parotid gland biopsy, collection of stimulated parotid gland saliva and parotid ultrasonography. Patients who were classified as primary Sjögren’s syndrome according to the ACR-EULAR criteria were included. Construct validity was assessed using Spearman’s correlation coefficients.

Results: A total of 41 patients with primary Sjögren’s syndrome were included. All patients completed a full work-up within a mean time interval of 2.6 months. Correlations between histopathological items and stimulated parotid salivary flow were poor to fair (ρ=-0.123 for focus score and ρ=-0.259 for percentage of CD45+ infiltrate). Likewise, poor correlations were observed between stimulated parotid salivary flow and parotid ultrasonography (ρ=-0.196). Moderate to good associations were found between histopathological items and parotid ultrasound scores (total ultrasound score: ρ=0.510 for focus score and ρ=0.560 for percentage of CD45+ infiltrate; homogeneity: ρ=0.574 for focus score and ρ=0.633 for percentage of CD45+ infiltrate).

Conclusion: Parotid gland salivary flow was not related to parotid gland histology, nor to parotid gland ultrasonography. Although pSS associated ultrasonographic findings correlated to some extent with the amount of inflammatory infiltrate in the parotid gland biopsy, we conclude that the three modalities that evaluate salivary gland involvement assess different (or at best partly related) constructs. Therefore, histopathology, salivary flow and ultrasonography are complementary measurements and cannot directly replace each other in the work-up of pSS.


Disclosures: M. van Ginkel, None; E. Mossel, None; E. Haacke, None; S. Arends, None; S. Liefers, None; K. Delli, None; J. van Nimwegen, None; A. Stel, None; F. Spijkervet, None; A. Vissink, BMS, 5, Roche, 5; B. van der vegt, None; F. Kroese, Bristol Myers Squibb, 5, Roche, 5; H. Bootsma, Bristol Myers Squibb, 2, 5, 6, Roche, 2, 5, Novartis, 2, 6, Medimmune, 2, Union Chimique Belge, 2.

To cite this abstract in AMA style:

van Ginkel M, Mossel E, Haacke E, Arends S, Liefers S, Delli K, van Nimwegen J, Stel A, Spijkervet F, Vissink A, van der vegt B, Kroese F, Bootsma H. Histopathology, Salivary Flow and Ultrasonography of the Parotid Gland: Three Complementary Measurements in Primary Sjögren’s Syndrome [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/histopathology-salivary-flow-and-ultrasonography-of-the-parotid-gland-three-complementary-measurements-in-primary-sjogrens-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/histopathology-salivary-flow-and-ultrasonography-of-the-parotid-gland-three-complementary-measurements-in-primary-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology